(Q46812655)

25 December 2017

title

Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial (English)

1 reference

25 December 2017

0 references

1 reference

1 reference

1 reference

E M Molyneux

1

1 reference

25 December 2017

A L Walsh

2

1 reference

25 December 2017

H Forsyth

3

1 reference

25 December 2017

M Tembo

4

1 reference

25 December 2017

J Mwenechanya

5

1 reference

25 December 2017

K Kayira

6

1 reference

25 December 2017

L Bwanaisa

7

1 reference

25 December 2017

A Njobvu

8

1 reference

25 December 2017

S Rogerson

9

1 reference

25 December 2017

G Malenga

10

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

25 December 2017

published in

The Lancet

1 reference

25 December 2017

volume

360

1 reference

25 December 2017

issue

9328

1 reference

25 December 2017

page(s)

211-218

1 reference

25 December 2017

Bacterial meningitis in the United States in 1995. Active Surveillance Team

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Dexamethasone and bacterial meningitis in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Glucocorticoids in central nervous system bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Treatment of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2909458-8

7 January 2021

10.1016/S0140-6736(02)09458-8

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017